Arima Genomics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $22M

  • Investors
  • 18

Arima Genomics General Information

Description

Developer of a gene-sequencing technology designed to accelerate the understanding of genome sequence and structure toward their role in human health and disease. The company's technology is a proximity ligation method that captures the three-dimensional organizational structure of chromatin, where genomic sequences that are closer to each other in the 3D space can be distal to each other in linear distance, thereby preserving long-range sequence and structure information before sequencing, enabling scientists to identify structural variants of genes and allowing the analysis of critical genetic information.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6404 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States
+1 (505)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Healthcare Technology Systems
Corporate Office
  • 6404 Nancy Ridge Drive
  • San Diego, CA 92121
  • United States
+1 (505)

Arima Genomics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arima Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC (Series C) 17-Jun-2025 $22M Completed Generating Revenue
16. Grant 01-May-2023 Completed Generating Revenue
15. Later Stage VC (Series B) 22-Jan-2022 Completed Generating Revenue
14. Grant 05-Apr-2021 Completed Generating Revenue
13. Accelerator/Incubator Completed Generating Revenue
12. Grant 01-Jan-2021 Completed Generating Revenue
11. Accelerator/Incubator Completed Generating Revenue
10. Debt - PPP 12-Apr-2020 Completed Generating Revenue
9. Later Stage VC (Series A) 24-Feb-2020 $3.7M $3.7M Completed Generating Revenue
8. Grant 01-Jan-2020 $2M Completed Generating Revenue
To view Arima Genomics’s complete valuation and funding history, request access »

Arima Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 4,850,000 $0.000100 8% $0.77 $0.77 1x $0.77 6.74%
To view Arima Genomics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Arima Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a gene-sequencing technology designed to accelerate the understanding of genome sequence and structure towa
Biotechnology
San Diego, CA
47 As of 2026

Santa Barbara, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arima Genomics Competitors (10)

One of Arima Genomics’s 10 competitors is Acuity Spatial Genomics, a Corporate Backed or Acquired company based in Santa Barbara, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Acuity Spatial Genomics Corporate Backed or Acquired Santa Barbara, CA
Quantapore Venture Capital-Backed South San Francisco, CA
Ozette Venture Capital-Backed Seattle, WA
Sphere Fluidics Formerly VC-backed Cambridge, United Kingdom
CosmosID Formerly VC-backed Germantown, MD
You’re viewing 5 of 10 competitors. Get the full list »

Arima Genomics Patents

Arima Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026080845-A1 Genetic alteration detection Pending 10-Oct-2024
WO-2025199450-A1 Methods of selecting and treating cancer subjects that are candidates for treatment using inhibitors of a pd-1 pathway Pending 22-Mar-2024
EP-4731779-A2 Methods and compositions for preparing extracellular vesicle nucleic acids that preserve spatial-proximity information and applications thereof Pending 21-Jun-2023
WO-2024263946-A2 Methods and compositions for preparing extracellular vesicle nucleic acids that preserve spatial-proximity information and applications thereof Inactive 21-Jun-2023
WO-2024263946-A3 Methods and compositions for preparing extracellular vesicle nucleic acids that preserve spatial-proximity information and applications thereof Inactive 21-Jun-2023 C12Q1/6886
To view Arima Genomics’s complete patent history, request access »

Arima Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arima Genomics Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Phase Two Ventures Venture Capital Minority
Genetron Health Corporation Minority
Hiaqua Investments Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Arima Genomics Investments (1)

Arima Genomics’s most recent deal was a Joint Venture with Aventa. The deal was made on 31-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aventa 31-Jan-2023 Joint Venture Biotechnology
To view Arima Genomics’s complete investments history, request access »

Arima Genomics FAQs

  • When was Arima Genomics founded?

    Arima Genomics was founded in 2015.

  • Where is Arima Genomics headquartered?

    Arima Genomics is headquartered in San Diego, CA.

  • What is the size of Arima Genomics?

    Arima Genomics has 47 total employees.

  • What industry is Arima Genomics in?

    Arima Genomics’s primary industry is Biotechnology.

  • Is Arima Genomics a private or public company?

    Arima Genomics is a Private company.

  • What is the current valuation of Arima Genomics?

    The current valuation of Arima Genomics is .

  • What is Arima Genomics’s current revenue?

    The current revenue for Arima Genomics is .

  • How much funding has Arima Genomics raised over time?

    Arima Genomics has raised $32.7M.

  • Who are Arima Genomics’s investors?

    , , Phase Two Ventures, Genetron Health, and Hiaqua Investments are 5 of 18 investors who have invested in Arima Genomics.

  • Who are Arima Genomics’s competitors?

    Acuity Spatial Genomics, Quantapore, Ozette, Sphere Fluidics, and CosmosID are some of the 10 competitors of Arima Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process